NewslettersCancer Stem Cell NewsMammary Cell News Toll-Like Receptor 2 Promotes Breast Cancer Progression and Resistance to Chemotherapy By lbeveridge - June 29, 2022 0 Scientists showed that high TLR2 expression is linked to poor prognosis in breast cancer patients, therefore representing a candidate target for breast cancer treatment. [Oncoimmunology] Full Article